[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ptau217-amyloid-1-42-plasma-ratio":3},{"name":4,"total":5,"trials":6},"pTau217\u002Fβ-Amyloid 1-42 Plasma Ratio",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07633470","A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)",[11],"Phase 4","RECRUITING","2026-08-03T03:26:30.254593Z","2026-06-14T18:39:22.254030Z"]